Target specific seminars in drug discovery--IBC conference. 24-26 April 2006, Berlin, Germany
Garvey, R.
IDrugs the investigational drugs journal 9(7): 474-475
2006
ISSN/ISBN: 1369-7056 PMID: 16821158 Document Number: 597025
Document emailed within 1 workday
Related Documents
Shen, Y. 2007: Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and Therapeutics IDrugs: the investigational drugs journal 10(12): 848-850Young, S.S. 1999: Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA IDrugs: the investigational drugs journal 2(7): 648-649
Samarsky, D. 2005: RNAi: From Biology to Therapeutics--Second Annual Conference. 30 January-1 February 2005, Berlin, Germany IDrugs: the investigational drugs journal 8(3): 219-221
F.W. Roush 1990: Distributive justice and inequality: a selection of papers given at a conference, Berlin, May 1986.: W. Gaertner and P.K. Pattanaik, Berlin: Springer-Verlag ,1988, 171 pages, 120 DM Mathematical Social Sciences 19(2): 203-0
Braddock, M. 2003: Inflammatory Processes in Drug Discovery - SRI Conference. 22-23 September 2003, Philadelphia, PA, USA IDrugs: the investigational drugs journal 6(11): 1049-1052
Matthiessen, W.; Kind, A.; Göbel, D. 1977: Epidemiology of primary drug resistance in tuberculosis in the Federal Republic of Germany including Berlin (West) during 1972 to 1975 Praxis und Klinik der Pneumologie 31(10): 890-898
Lowe, J.A.; Jones, P.; Wilson, D.M. 2009: The importance of target validation in drug discovery and development Current Opinion in Drug Discovery and Development 12(5): 581-584
Imaizumi, Y.; Kaneko, S. 2011: Study on ion channel transporters as a target for the drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 138(6): 227
Płocinska, R.; Korycka-Machala, M.; Plocinski, P.; Dziadek, J. 2017: Mycobacterial DNA Replication as a Target for Antituberculosis Drug Discovery Current Topics in Medicinal Chemistry 17(19): 2129-2142
Haramura, M. 2007: Application of chemical biology to proteomics in drug target discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 129(2): 124-128
Lavery, K.S.; King, T.H. 2003: Antisense and RNAi: powerful tools in drug target discovery and validation Current Opinion in Drug Discovery and Development 6(4): 561-569
Golz, S.; Jörg Hüser 2007: Discovery of a New Drug - From Target Identification to Ultra-High-Throughput Screening Clinical Laboratory 53(1-2): 77-79
Kojima, H.; Okabe, T.; Nagano, T. 2013: Open innovation center for drug discovery: a research-supporting network for drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(6): 327-332
Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95
1993: Berlin conference review Aids Care 5(4): 471-525
Kelaher, M. 1993: Report from Berlin: ninth AIDS conference--prevention Australian Journal of Public Health 17(4): 390-392
Pan, E.Y.; Sobieraj, D.M. 2016: Considerations for Prescribing Target-Specific Oral Anticoagulants in the Setting of Renal Dysfunction or Drug Interactions Connecticut Medicine 80(2): 105-111
Harrison, R. 2003: Kinases--SMi conference: 9-10 April 2003, London, UK IDrugs: the investigational drugs journal 6(6): 560-562
Weisskopf, V. 2014: The hospital at Hillersleben Germany, April 1945 Harefuah 153(3-4): 215-8 236 235
1992: Hyperthermia in Clinical Oncology. 6th European BSD Users' Conference. Berlin, October 2-3, 1992. Abstracts Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 168(11): 646-674